Business Context and Reporting Period
This Form 8-K was filed by NeuroBo Pharmaceuticals, Inc. (NRBO) on August 23, 2023. The filing reports the entry into a new material definitive lease agreement and the termination of an existing lease for the company's principal executive offices in Boston, Massachusetts.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on the terms of a new office lease.
- New Lease Annual Rent (Year 1): $85,435.00
- New Lease Annual Rent (Year 2): $87,998.05
- New Lease Annual Rent (Year 3): $90,634.33
- Extension Option Rent (Year 4): $93,343.84
- Extension Option Rent (Year 5): $96,150.99
- Lease Term: 3 years initial, with an option to extend for 2 additional years.
- Premises Size: Approximately 2,441 square feet.
Material Changes
The company is relocating its corporate headquarters effective September 1, 2023.
- New Location: 177 Huntington Avenue, Suite 1732 (also known as 545 Concord Avenue), Boston, MA.
- Previous Location: 200 Berkeley Street, 19th Floor, Boston, MA (lease terminated effective September 30, 2023).
- Landlord Change: Transitioning from an entity affiliated with WeWork Inc. to Alewife Properties LLC.
Outlook, Risks, and Contingencies
The filing outlines standard lease contingencies and risks:
- Default Provisions: The landlord may terminate the agreement with three days' prior written notice if the company fails to pay rent or breaches terms, provided the failure continues for 30 days after written notice.
- Insurance: The company is required to maintain insurance throughout the tenancy.
- Indemnification: The agreement includes customary indemnification clauses.
- Extension Notice: To exercise the two-year extension option, the company must provide at least nine months' notice prior to the end of the initial term.
Investor Verification Checklist
- Verify the full text of the Lease Agreement when filed as an exhibit to the Form 10-Q for the period ending September 30, 2023.
- Confirm the actual move-in date of September 1, 2023, and the cessation of payments at the previous location.
- Monitor the company's cash flow to ensure it can meet the fixed annual rent obligations starting in the third quarter of 2023.
- Check for any additional costs associated with the relocation not detailed in this summary (e.g., moving expenses, build-out costs).